Methyl-donor supplementation in obese mice prevents the progression of NAFLD, activates AMPK and decreases acyl-carnitine levels.

Methyl-donor supplementation in obese mice prevents the progression of NAFLD, activates AMPK and decreases acyl-carnitine levels.
复制标题

DOI:
10.1016/j.molmet.2014.04.010
复制
发表时间:
2014-08
影响因子:
8.1
通讯作者:
Daniel H
Daniel H
中科院分区:
医学1区
文献类型:
--
作者:
Dahlhoff C;Worsch S;Sailer M;Hummel BA;Fiamoncini J;Uebel K;Obeid R;Scherling C;Geisel J;Bader BL;Daniel H

文献摘要

参考文献

被引文献

相似文献

非酒精性脂肪性肝病(NAFLD)是由肝脏脂质积累增加和脂肪变性引起的,与肝脏一碳(C1)代谢密切相关。我们在C57 BL 6/N小鼠中评估了由高脂肪(HF)饮食诱导的8周以上的NAFLD是否可以通过另外4周的饮食甲基供体补充(MDS)逆转。肥胖小鼠中的MDS未能逆转NAFLD,但阻止了与关键肝脏C1代谢物(例如S-腺苷甲硫氨酸和S-腺苷高半胱氨酸)的主要变化相关的肝脂肪变性的进展。AMPK-α磷酸化水平的增加以及β-HAD活性的增强表明通过脂肪酸氧化途径的通量增加。这得到了伴随的肝脏游离脂肪酸和酰基肉毒碱水平降低的支持。虽然HF饮食改变了肝脏磷脂模式,但MDS没有改变。我们的研究结果表明,膳食甲基供体激活AMPK,这是脂肪酸β-氧化控制中的关键酶,介导脂肪酸利用增加,从而防止肝脏脂质进一步蓄积。
Non-alcoholic fatty liver disease (NAFLD) results from increased hepatic lipid accumulation and steatosis, and is closely linked to liver one-carbon (C1) metabolism. We assessed in C57BL6/N mice whether NAFLD induced by a high-fat (HF) diet over 8 weeks can be reversed by additional 4 weeks of a dietary methyl-donor supplementation (MDS). MDS in the obese mice failed to reverse NAFLD, but prevented the progression of hepatic steatosis associated with major changes in key hepatic C1-metabolites, e.g. S-adenosyl-methionine and S-adenosyl-homocysteine. Increased phosphorylation of AMPK-α together with enhanced β-HAD activity suggested an increased flux through fatty acid oxidation pathways. This was supported by concomitantly decreased hepatic free fatty acid and acyl-carnitines levels. Although HF diet changed the hepatic phospholipid pattern, MDS did not. Our findings suggest that dietary methyl-donors activate AMPK, a key enzyme in fatty acid β-oxidation control, that mediates increased fatty acid utilization and thereby prevents further hepatic lipid accumulation.
DOI: 10.1073/pnas.0705070104
发表时间: 2007-07-17
影响因子: 11.1
作者:
Jaeger, Sibylle;Handschin, Christoph;Spiegelman, Bruce M.
通讯作者: Spiegelman, Bruce M.
DOI: 10.1002/hep.22159
发表时间: 2008-04-01
期刊: HEPATOLOGY
影响因子: 13.5
作者:
Martinez-Chantar, M. Luz;Vazquez-Chantada, Mercedes;Mato, Jose M.
通讯作者: Mato, Jose M.
DOI: 10.1016/s0016-5085(03)00276-2
发表时间: 2003-05-01
期刊: GASTROENTEROLOGY
影响因子: 29.4
作者:
Ji, C;Kaplowitz, N
通讯作者: Kaplowitz, N
DOI: 10.1152/ajpgi.00249.2010
发表时间: 2010-11-01
影响因子: 4.5
作者:
Kathirvel, Elango;Morgan, Kengathevy;Morgan, Timothy R.
通讯作者: Morgan, Timothy R.